OR (95%CI) | p value | |
---|---|---|
Determinants of annual total healthcare cost | ||
Female | 1.21 (0.7–2.1) | 0.48 |
Age at SSc onset*, years | 1.03 (1.0–1.1) | < 0.001 |
Caucasian ethnicity | 0.55 (0.2–1.6) | 0.27 |
Diffuse subtype | 0.71 (0.4–1.2) | 0.19 |
ILD | 1.38 (0.9–2.2) | 0.16 |
PAH# | 1.78 (0.9–3.2) | 0.05 |
PDE-5-inhibitor | 1.0 (0.6–1.8) | 0.99 |
Iloprost | 1.77 (1.1–2.8) | 0.02 |
Determinants of hospital cost | ||
Female | 1.20 (0.7–2.1) | 0.49 |
Caucasian ethnicity | 0.83 (0.3–2.3) | 0.72 |
Age at SSc onset*, years | 1.03 (1.0–1.1) | 0.001 |
Diffuse subtype | 0.97 (0.6–1.6) | 0.91 |
PAH# | 1.32 (0.7–2.3) | 0.35 |
ILD | 1.27 (0.8–1.9) | 0.29 |
Iloprost | 1.59 (1.0–2.5) | 0.04 |
PDE5 inhibitor | 1.13 (0.6–1.9) | 0.68 |
Determinants of ED cost | ||
Female | 1.29 (0.7–2.3) | 0.39 |
Caucasian ethnicity | 0.96 (0.3–2.8) | 0.94 |
Age at SSc onset*, years | 1.02 (0.9–1.0) | 0.06 |
Diffuse subtype | 0.79 (0.5–1.3) | 0.37 |
PAH# | 2.89 (1.4–5.9) | 0.004 |
ILD | 1.29 (0.8–2.1) | 0.33 |
Determinants of MBS cost | ||
Female | 1.79 (1.0–3.2) | 0.05 |
Age at SSc onset*, years | 1.02 (1.0–1.1) | 0.001 |
Caucasian ethnicity | 0.82 (0.3–2.5) | 0.001 |
Diffuse subtype | 0.68 (0.4–1.1) | 0.10 |
PAH# | 2.41 (1.3–4.5) | 0.001 |
DU severity** | ||
Mild | Baseline | |
Moderate | 1.05 (0.6–1.9) | 0.88 |
Severe | 0.71 (0.3–1.6) | 0.39 |
CVA | 3.35 (1.1–10.4) | 0.04 |
Diabetes mellitus | 1.51 (0.6–3.8) | 0.39 |